Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese Patients

Summary

This is a 52-week, multi-center, randomized, open label, parallel group study to assess the long term safety and tolerability of once-daily NVA237, using tiotropium as an active control, in Japanese patients with moderate to severe chronic obstructive pulmonary disease (COPD) .

Timeline

Start

2010-05

Primary completion

2011-11

Completion

—

Drugs

Indications